Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

4.7

Target Price

Analyst Recom

3

Performance Q

-57.39

Relative Volume

Beta

-0.64

Ticker: OPGN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-07OPGN5.02N/AN/A0
2025-07-08OPGN4.93N/AN/A0
2025-07-09OPGN4.6N/AN/A0
2025-07-10OPGN4.55N/AN/A0
2025-07-11OPGN4.78N/AN/A0
2025-07-14OPGN4.78N/AN/A0
2025-07-15OPGN4.05N/AN/A0
2025-07-16OPGN4.6N/AN/A0
2025-07-17OPGN4.7N/AN/A0
2025-07-18OPGN4.7N/AN/A0
2025-07-21OPGN4.7N/AN/A0
2025-07-22OPGN4.7N/AN/A0
2025-07-23OPGN0.0393N/AN/A0
2025-07-24OPGN0.0393N/AN/A0
2025-07-25OPGN0.0393N/AN/A0
2025-07-28OPGN0.0393N/AN/A0
2025-07-29OPGN0.0393N/AN/A0
2025-07-30OPGN0.0393N/AN/A0
2025-07-31OPGN0.0393N/AN/A0
2025-08-01OPGN0.0393N/AN/A0
2025-08-04OPGN0.0393N/AN/A0
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-07OPGN4.75- - -10.37
2025-07-08OPGN3.50- - -10.37
2025-07-09OPGN4.60- - -10.37
2025-07-10OPGN4.55- - -10.37
2025-07-11OPGN4.05- - -10.37
2025-07-14OPGN3.40- - -10.37
2025-07-15OPGN4.01- - -10.37
2025-07-16OPGN3.72- - -10.37
2025-07-17OPGN4.70- - -10.37
2025-07-18OPGN4.70- - -10.37
2025-07-21OPGN4.70- - -10.37
2025-07-22OPGN4.70- - -10.37
2025-07-23OPGN4.70- - -10.37
2025-07-24OPGN4.70- - -10.37
2025-07-25OPGN4.70- - -10.37
2025-07-28OPGN4.70- - -10.37
2025-07-29OPGN4.70- - -10.37
2025-07-30OPGN4.70- - -10.37
2025-07-31OPGN4.70- - -10.37
2025-08-01OPGN4.70- - -10.37
2025-08-04OPGN4.70- - -10.37
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




No data found

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

-0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

18

Growth Score

25

Sentiment Score

80

Actual DrawDown %

99.5

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

6.13

P/B

P/Free Cash Flow

EPS

-40.32

Average EPS Est. Cur. Y​

-10.37

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-356

Return on Equity vs Industry %

-350.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-4.18

EBIT Estimation

OpGen, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees:
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
stock quote shares OPGN – Opgen Inc Stock Price stock today
news today OPGN – Opgen Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch OPGN – Opgen Inc yahoo finance google finance
stock history OPGN – Opgen Inc invest stock market
stock prices OPGN premarket after hours
ticker OPGN fair value insiders trading